Occurrence of Left Ventricular Hypertrophy in Subjects with Metabolic Syndrome: Role of Adiponectin
Journal: Journal of Dibetes and Obesity (Vol.4, No. 1)Publication Date: 2017-02-20
Authors : Rosario Scaglione;
Page : 7-10
Keywords : Adiponectin; Metabolic syndrome; Left ventricular hypertrophy;
Abstract
This study was designed to evaluate the role of total plasma adiponectin (ADPN) on the occurrence of left ventricular hypertrophy in subjects with metabolic syndrome (MetS) compared to a control group without MetS. The main finding of our study concerns the independent predictor role of ADPN in the occurrence of LVH in all the patients studied. Accordingly, circulating ADPN might be considered a nonhaemodynamic factor of LVH in subjects with MetS.
Other Latest Articles
- Sildenafil Associated Threatened Ischemic Stroke Reversed with Alteplase
- Normal Pressure Hydrocephalus Secondary to Intracranial Mass: A Case Series
- Breast Cancer Stem Cells: Understanding and Opportunities for Therapeutics
- MRI Diagnosis in Classical Metachromatic Leukodystrophy
- A Practical Guide to Sedation and Analgesia in Paediatric Intensive Care Unit (ICU)
Last modified: 2017-12-16 15:30:20